Tue, October 24, 2017
Mon, October 23, 2017
Fri, October 20, 2017

Joseph Schwartz Maintained (AUPH) at Buy with Increased Target to $14 on, Oct 23rd, 2017

Joseph Schwartz of Leerink Swann, Maintained "Aurinia Pharmaceuticals Inc." (AUPH) at Buy with Increased Target from $10 to $14 on, Oct 23rd, 2017.

Joseph has made no other calls on AUPH in the last 4 months.



There is 1 other peer that has a rating on AUPH. Out of the 1 peers that are also analyzing AUPH, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • John Newman of "Canaccord Genuity" Downgraded from Strong Buy to Buy on, Wednesday, September 13th, 2017